Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01802580 · ClinicalTrials.gov registry record · Early Phase 1
Using an Internet Study to Improve Adherence for Psoriasis Patients
A Early Phase 1 study, sponsored by Wake Forest University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 40
- Enrollment target
NCT01802580 is a Early Phase 1 study that has completed, run by Wake Forest University. The registered enrollment target is 40 participants.
The verdict
NCT01802580, a Early Phase 1 study, has completed, sponsored by Wake Forest University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
To evaluate whether participation in an Internet-based intervention helps improve short-term and long-term psoriasis treatment outcomes, in particular, adherence.
Interventions
- BEHAVIORAL Internet Survey
- DRUG fluocinonide 0.05% ointment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2012-10 |
| Est. Completion | 2016-04 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01802580
The ClinicalTrials.gov registry entry for NCT01802580 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University, which has 100 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Internet Survey is the first listed.
NCT01802580 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01802580 about?
NCT01802580 is a clinical study titled "Using an Internet Study to Improve Adherence for Psoriasis Patients". To evaluate whether participation in an Internet-based intervention helps improve short-term and long-term psoriasis treatment outcomes, in particular, adherence.
What is the current status of trial NCT01802580?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 40 participants. The study started on 2012-10. Estimated completion is 2016-04.
What interventions are being tested in trial NCT01802580?
The interventions under investigation include: Internet Survey (BEHAVIORAL), fluocinonide 0.05% ointment (DRUG).
Who is sponsoring clinical trial NCT01802580?
This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.